In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts

Annals of Hematology

Volumn 75, Issue 4, 1997, Pages 145-147

  Pisani, F ^a   Del Poeta, G ^a   Aronica, G ^a   Venditti, A ^a   Caravita, T ^a   Amadori, S ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

AML; ATRA; Bcl 2; CD34

Indexed keywords

PROTEIN BCL 2; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; BLAST CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CELL DEATH; CELL STRAIN HL 60; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; DOWN-REGULATION; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; PROTO-ONCOGENE PROTEINS C-BCL-2; TRETINOIN;

EID: 0030668661     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050332     Document Type: Article

References (11)

1. Bradbury DA, Russell NH (1995) Comparative quantitative expression of bcl-2 normal and leukaemic myeloid cells. Br J Haematol 91:374-379
2. Bradbury DA, Aldington S, Zhu Y-M, Russell NH (1996) Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression. Br J Haematol 94:671-675
3. Campos L, Ronault J-P, Sabiolo O, Oriol P, Roubi N, Vasselan C, Archimbaud E (1993) High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81:3091-3096
4. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti MA, Porta GD(1992) Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79:1291-1298
5. Del Poeta G, Venditti A, Aronica G, Cox MC, Bruno A, Buccisano F, Tamburini A, Suppo G, Simone MD, Cordero V, Tufilli V, Maffei L, Amadori S (1996) High proliferative rate detected by transferrin receptor is associated both with low intensity of bcl-2 expression and poor outcome in acute myeloid leukemia (AML). Blood 88 [Suppl 83]:(abs 330)
6. Hu Z-B, Minden MD, McCulloch EA (1995) Direct evidence for the participation of bcl-2 in the regulation by retinoic-acid of the Ara-C sensitivity of leukemic stem cells. Leukemia 9:1667-1673
7. Keith FJ, Bradbury DA, Zhu Y-M, Russell NH (1995) Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C. Leukemia 9:131-138
8. Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in human leukemia cell line. Blood 81:151-157
9. Reed JC, Kitada S, Takayama S, Miyashita T (1994) Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines. Ann Oncol 5 [Suppl 1]:S61-65
10. Venditti A, Stasi R, Del Poeta G, Buccisano F, Aronica G, Bruno A, Pisani F, Caravita T, Masi M, Tribalto M, Simone MD, Avvisati G, Amadori S, Papa G (1995) All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemia. Leukemia 9:1121-1125
11. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW (1993) Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin-induced apoptosis. Cancer Res 53:1853-1861